Durant F - Search Results

1

Terbogrel, a dual-acting agent for thromboxane receptor antagonism and thromboxane synthase inhibition.

Michaux C, Norberg B, Dogné JM, Durant F, Masereel B, Delarge J, Wouters J. Michaux C, et al. Among authors: durant f. Acta Crystallogr C. 2000 Oct;56 ( Pt 10):1265-6. doi: 10.1107/s0108270100009872. Acta Crystallogr C. 2000. PMID: 11025320

2

N-(3-Phenoxy-4-pyridinio)methanesulfonamidate.

Michaux C, Charlier C, Julémont F, Dogné JM, de Leval X, Norberg B, Pirotte B, Durant F. Michaux C, et al. Among authors: durant f. Acta Crystallogr C. 2002 Feb;58(Pt 2):o88-9. doi: 10.1107/s0108270101018595. Epub 2002 Jan 23. Acta Crystallogr C. 2002. PMID: 11828118

3

N-tert-butyl-N'-(2-cyclohexylamino-5-nitrobenzenesulfonyl)urea, BM531, a dual-acting agent for thromboxane receptor antagonism and thromboxane synthase inhibition.

Michaux C, Dogné JM, Norberg B, Durant F, Masereel B. Michaux C, et al. Among authors: durant f. Acta Crystallogr C. 2002 Oct;58(Pt 10):o621-3. doi: 10.1107/s0108270102016463. Epub 2002 Sep 30. Acta Crystallogr C. 2002. PMID: 12359948

4

A pharmacophore model for sulphonyl-urea (-cyanoguanidine) compounds with dual action, thromboxane receptor antagonists and thromboxane synthase inhibitors.

Michaux C, Dogné JM, Rolin S, Masereel B, Wouters J, Durant F. Michaux C, et al. Among authors: durant f. Eur J Med Chem. 2003 Jul-Aug;38(7-8):703-10. doi: 10.1016/s0223-5234(03)00076-x. Eur J Med Chem. 2003. PMID: 12932901

5

Three 5H-indeno[1,2-c]pyridazin-5-one derivatives, potent type-B monoamine oxidase inhibitors.

Frédérick R, Norberg B, Durant F, Ooms F, Wouters J. Frédérick R, et al. Among authors: durant f. Acta Crystallogr C. 2004 Sep;60(Pt 9):o623-6. doi: 10.1107/S0108270104014660. Epub 2004 Aug 11. Acta Crystallogr C. 2004. PMID: 15345837

6

Antagonism of the TXA2 receptor by seratrodast: a structural approach.

Wouters J, Durant F, Masereel B. Wouters J, et al. Among authors: durant f. Bioorg Med Chem Lett. 1999 Oct 4;9(19):2867-70. doi: 10.1016/s0960-894x(99)00490-4. Bioorg Med Chem Lett. 1999. PMID: 10522708

7

Structural analysis of pyrrolidinones.

Camus F, Norberg B, Legrand A, Rigo B, Durant F, Wouters J. Camus F, et al. Among authors: durant f. Acta Crystallogr C. 2000 Feb;56 ( Pt 2):193-6. doi: 10.1107/s0108270199013037. Acta Crystallogr C. 2000. PMID: 10777884 No abstract available.

8

Structure determination and comparison of BM567, a sulfonylurea, with terbogrel, two compounds with dual action, thromboxane receptor antagonism and thromboxane synthase inhibition.

Michaux C, Rolin S, Dogné JM, Durant F, Masereel B, Delarge J, Wouters J. Michaux C, et al. Among authors: durant f. Bioorg Med Chem Lett. 2001 Apr 23;11(8):1019-22. doi: 10.1016/s0960-894x(01)00114-7. Bioorg Med Chem Lett. 2001. PMID: 11327579

9

Design, synthesis and biological evaluation of a sulfonylcyanoguanidine as thromboxane A2 receptor antagonist and thromboxane synthase inhibitor.

Dogné JM, Wouters J, Rolin S, Michaux C, Pochet L, Durant F, Delarge J, Masereel B. Dogné JM, et al. Among authors: durant f. J Pharm Pharmacol. 2001 May;53(5):669-80. doi: 10.1211/0022357011775992. J Pharm Pharmacol. 2001. PMID: 11370706

10

Pyrazolidine-3,5-dione angiotensin-II receptor antagonists.

Cauvin C, Le Bourdonnec B, Norberg B, Hénichart JP, Durant F. Cauvin C, et al. Among authors: durant f. Acta Crystallogr C. 2001 Nov;57(Pt 11):1330-2. doi: 10.1107/s0108270101013506. Epub 2001 Nov 13. Acta Crystallogr C. 2001. PMID: 11706265

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters